MedTrace Logo

Effect of Sciatic Nerve Neurodynamic Sliding on Pain, Disability, and Balance in Patients With Lumbar Radiculopathy

NCT07458399 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2026-03-09

No results posted yet for this study

Summary

This study will be conducted to evaluate the effect of sciatic nerve slider mobilization on pain intensity. Also, to evaluate the impact of sciatic nerve mobilization on functional disability, and to determine the influence of sciatic nerve slider neurodynamics on functional balance performance.

Conditions

  • Lumbar Radiculopathy

Interventions

OTHER

Selected conventional physical therapy program

The program will include: 1- Transcutaneous electrical nerve stimulation (TENS) will be applied at Lumbosacral area, with pulse frequency of 100 Hz for 15 minutes. 2\) Manual therapy intervention: Myofascial release will be performed on low back muscles and gluteus, piriformis, hamstring, and calf of the affected lower extremity applied for 20 minutes. Following side posture positional distraction, the wedge pillow will be removed and the patient is maintained in the same position. The physical therapist performed passive spinal rotation mobilization. Finally, high-velocity low-amplitude (HVLA) manipulation will be applied from the same position. 3\) Core stability exercises: They are consisted of of side plank on knee or ankle on both sides, and clamshell exercise. The clamshell exercise consists of three sets of ten repetitions. Side plank will be performed three times in a static manner for 10-20 seconds or up to patient failure.

OTHER

Sciatic nerve slider mobilization

Mobilization will be applied from supine position, alternating hip flexion with knee extension and dorsiflexion, and knee flexion with plantar flexion, performed three times for 1 minute straight leg raising technique rhythmically

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ebtesam Fahmy, Professor · Cairo University

  • Rasha El-Rewainy, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2026-09-15
Completion
2026-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07458399 on ClinicalTrials.gov